Stonebridge Capital Advisors’s Organon & Co OGN Stock Holding History

Stonebridge Capital Advisors’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-801	Closed	-$13.9K	–	633
2023 Q3	$13.9K	Buy	801 +55	+7%	+$1.15K	﹤0.01%	553
2023 Q2	$15.5K	Sell	746 -23	-3%	-$500	﹤0.01%	546
2023 Q1	$18.1K	Sell	769 -47	-6%	-$1.26K	﹤0.01%	529
2022 Q4	$22.8K	Sell	816 -38	-4%	-$972	﹤0.01%	477
2022 Q3	$20K	Sell	854 -9	-1%	-$272	﹤0.01%	467
2022 Q2	$29K	Sell	863 -15	-2%	-$525	﹤0.01%	433
2022 Q1	$31K	Sell	878 -9,463	-92%	-$324K	﹤0.01%	465
2021 Q4	$315K	Sell	10,341 -456	-4%	-$14.9K	0.03%	169
2021 Q3	$354K	Sell	10,797 -143	-1%	-$4.58K	0.04%	149
2021 Q2	$331K	Buy	+10,940	New	+$360K	0.04%	152

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Stonebridge Capital Advisors's OGN Position: Q4 2023 in Review

Stonebridge Capital Advisors sold out of Organon & Co (OGN) in Q4 2023, closing a stake of 801 shares — an estimated $13.9K sold.

Stonebridge Capital Advisors first reported a position in OGN in Q2 2021 and held it in 10 quarters. The position peaked at $354K in Q3 2021. 719 funds tracked by Wall St. Rank hold OGN as of Q4 2023.

Stonebridge Capital Advisors reported no remaining Organon & Co position as of Q4 2023 after selling out during the quarter.
Stonebridge Capital Advisors sold 801 Organon & Co shares in Q4 2023, an estimated $13.9K.
Stonebridge Capital Advisors first reported a position in Organon & Co in Q2 2021 and held it in 10 quarters.
Stonebridge Capital Advisors's Organon & Co position peaked at $354K in Q3 2021.
719 funds tracked by Wall St. Rank held Organon & Co as of Q4 2023.

Based on Stonebridge Capital Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.